The radiochemist applies extensive knowledge of clinical radiopharmaceuticals to ensure the quality of investigational radiopharmaceuticals specified by the standards stated in the USP Chapter <823> and the laboratory requirements of 21 CFR 212. This position will report to the Director of the Radiopharmaceutical Facility in the development of standard operating procedures for the investigational PET drugs such that the facilities, equipment, and inventory control meet the associated regulatory requirements. This position will also assist in creating new approaches in the synthesis and labeling of novel radiopharmaceuticals for clinical use, and in working with the director in writing investigational drug applications (IND) and Abbreviated New Drug Applications (ANDA). The background for this position requires a minimum of an MS in chemistry or a related subject; Ph.D. and experience in drug production/development are preferred.
The University of California, San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and high-quality patient care. It is the only UC campus in the 10-campus system dedicated exclusively to the health sciences.